Left atrial appendage occlusion - Closure or just the beginning?

New England Journal of Medicine

Volumn 360, Issue 25, 2009, Pages 2601-2603

  Maisel, William H ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; NITINOL; WARFARIN;

ARTERY OCCLUSION; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DEVICE THERAPY; DRUG EFFICACY; HEART ARRHYTHMIA; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART VALVE SURGERY; HUMAN; PERICARDIAL EFFUSION; PRIORITY JOURNAL; SHORT SURVEY; STROKE; THROMBOEMBOLISM; THROMBUS;

EID: 67649104124     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp0903763     Document Type: Article

References (5)

1. Fuster V, Rydén LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114(7):e257-e354. [Erratum, Circulation 2007;116(6):e138.]
2. Food and Drug Administration. Circulatory Devices Panel Meeting: April 23, 2009, briefing information. (Accessed May 28, 2009, at http://www.fda.gov/ ohrms/dockets/ac/09/briefing/2009-4434b1-00-Index.html.)
3. Halperin JL, Gomberg-Maitland M. Obliteration of the left atrial appendage for prevention of thromboembolism. J Am Coll Cardiol 2003;42:1259-1261 (Pubitemid 37203397)
4. Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008;118(15):e523-e661.
5. National Institutes of Health. ClinicalTrials.gov: atrial fibrillation. (Accessed May 28, 2009, at http://clinicaltrials.gov/ct2/results?term= atrial+fibrillation.)